[Overcoming therapy resistance in prolactinomas: from perspectives to real clinical practice]. [PDF]
Probl Endokrinol (Mosk)Shutova AS +7 more
europepmc +1 more source
[Regional target program «Prevention of iodine deficiency diseases for 202X-202X»]. [PDF]
Probl Endokrinol (Mosk), 2022 Troshina EA +6 more
europepmc +1 more source
[Donohue syndrome and use of continuous subcutaneous IGF1 pump therapy]. [PDF]
Probl Endokrinol (Mosk), 2022 Melikyan MA +5 more
europepmc +1 more source
[Adaptation of the 12-item medication adherence scale ( the Questionnaire for assessment of adherence to Medication) on a Russian-speaking sample of patients with type 1 and type 2 diabetes mellitus]. [PDF]
Probl Endokrinol (Mosk)Epishin VE +7 more
europepmc +1 more source
[Melatonin status in obese patients with ovarian dysfunction at reproductive age]. [PDF]
Probl Endokrinol (Mosk), 2022 Andreeva EN +4 more
europepmc +1 more source
[Role of the state register of diabetes mellitus in assessing the epidemiological situation in Kyrgyzstan and Bishkek]. [PDF]
Probl Endokrinol (Mosk)Sultanalieva RB +2 more
europepmc +1 more source
[Puberty induction in boys with congenital isolated hypogonadotropic hypogonadism]. [PDF]
Probl Endokrinol (Mosk), 2023 Kokoreva KD +3 more
europepmc +1 more source
[Iodine status of the population in the WHO European Region (an abridged translation of selected sections of the WHO European report)]. [PDF]
Probl Endokrinol (Mosk)Gerasimov GA.
europepmc +1 more source
[Evolution of insulin therapy: past, present, future]. [PDF]
Probl Endokrinol (Mosk)Kurkin DV +13 more
europepmc +1 more source
[Growth hormone - 30 years of clinical practice: past, present, future]. [PDF]
Probl Endokrinol (Mosk)Dedov II +5 more
europepmc +1 more source